Paeds Cases · genetics-dysmorphology-and-metabolism
Counsel parents on a genomic test result, a secondary finding, and cascade testing — OSCE
OSCE communication and shared decision-making station: explaining to parents what their son's trio exome result means, why the normal microarray did not detect it, what a likely pathogenic variant is, what a secondary finding is and why it was reported, what cascade testing of the wider family involves, and why periodic re-analysis matters — while addressing parental guilt, anxiety about a cardiac finding, and the temptation to over-interpret uncertainty.
On this page & tools
Target exams
Task
Counsel the parents. You have five minutes. Demonstrate an organised, empathic, and accurate explanation that addresses four questions a fellowship communication station rewards: why the earlier microarray was normal and what the exome found, what the likely pathogenic variant means for their son, what the secondary cardiac finding means and why it was reported, and what cascade testing and re-analysis involve for the wider family. The management and counselling framework follows the ACMG/AMP variant classification standards and the ACMG SF v3.0 policy. [1] [5]
What the family needs to hear
Open by acknowledging the anxiety and naming the guilt. They feel responsible for passing on a genetic change — name this directly and dissolve it: genetic changes happen naturally and are carried silently through families for generations, often with no one knowing, and no one caused it or chose it. Then address the earlier test so they do not lose trust in the system. The chromosomal microarray they had was the right first test — it looks for missing or extra chunks of chromosome. It came back normal, which is good news, but it cannot see the very small changes in the DNA code that cause most single-gene conditions. That is why we did the exome test, which reads the genes letter by letter, and it has now found the answer. [1] [9]
Explain in plain language what the likely pathogenic variant means. Their son has a small change in a single gene that affects how his brain develops — this explains his developmental delay. The word "likely pathogenic" means the laboratory is highly confident (over 90 percent) that this change causes the condition. This is not a guess: it is based on careful comparison with genetic databases, computational tools, and published studies of other children with the same gene change. The result does not change who he is, but it does give us a name for what is happening, which unlocks support, services, and connections to other families. [1]
The secondary cardiac finding
Address the cardiac finding directly, because it is the source of their anxiety. During the exome, the laboratory also looked at a list of genes — about 73 of them — that are known to cause conditions we can do something about, like certain heart rhythm problems. This is called a secondary finding. The family agreed to this at the first visit. Their son was found to carry a change in one of these heart-rhythm genes. This is separate from his developmental delay — it is not the cause of his learning difficulty — but it is important because it means we now know to look after his heart. [5]
Reassure them that having the gene change does not mean he is unwell right now. It means he has a higher chance of a heart rhythm problem, so we will refer him to a cardiologist for a heart tracing and an ultrasound, and we will follow him over time. This is surveillance, not a diagnosis of illness — it is the advantage of knowing early. If the cardiologist recommends anything, such as medication or activity advice, we will discuss it together. [5]
Cascade testing and closing
Close with the family-testing conversation and the plan for the future. Because this gene change runs in families, we would like to test both parents to see who carries it — this tells us whether it came from one of you or arose newly in your son, which changes the counselling for other family members. We would also offer to test his siblings, and we can support you in sharing the information with the wider family if you wish. The genetics service coordinates this with sensitivity. [9]
Finally, explain that genetic knowledge is always growing. Even though we have found the answer today, we will keep this result under review. Every 2 to 3 years, we can re-analyse the same data with updated knowledge, in case new information refines our understanding. Give a written summary, a named contact, and a follow-up appointment. Thank them, affirm that having the answer is exactly the advantage their son now has, and confirm that the plan is shared across the genetics service, the cardiologist, the school, and their general practitioner. [5] [9]
References
- [1]Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med, 2015.PMID 25741868
- [5]Miller DT, Lee K, Chung WK, et al. ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement. Genet Med, 2021.PMID 34012068
- [7]Willig LK, Petrikin JE, Smith LD, et al. Whole-genome sequencing for identification of Mendelian disorders in critically ill newborns. Lancet Respir Med, 2015.PMID 25937001
- [9]Manickam K, McClain MR, Demmer LA, et al. Exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability: an evidence-based clinical guideline of the ACMG. Genet Med, 2021.PMID 34211152